THE’Advil, the Spasfon, Imodium, Ketum, or even Aerius, so many drugs with blue labels that will be reimbursed less by Health Insurance from this Monday, May 2.
The High Authority of Health (HAS) having judged that their therapeutic interest was “moderate”, they will therefore be reimbursed up to 30% instead of 35% like 1000 other drugs. You can also consult the entire list on the Official Journal website, dated April 6, 2011: http://journal-officiel.gouv.fr
But the blue stickers are not the only ones concerned! The reimbursement of “medical devices for individual use” (dressings, syringes, prostheses, implants, etc.) also drops by 5% from May 2 (60% instead of 65%). Other medical devices reimbursed so far at 65% have also seen their reimbursement reduced to 60%.
